Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
life sciences
5
×
national blog main
amgen
boston blog main
cholesterol
clinical trials
inclisiran
new york blog main
new york top stories
regeneron pharmaceuticals
biotech
boston top stories
national top stories
new york
praluent
repatha
alirocumab
alnylam pharmaceuticals
detroit blog main
detroit top stories
evolocumab
heart attack
ldl
medicines co.
mt sinai hospital
pcsk9
pcsk9 inhibitors
prashant vaishnava
san francisco blog main
san francisco top stories
sanofi
statins
stroke
the medicines co.
bempedoic acid
boulder/denver blog main
boulder/denver top stories
cardiac
cardiovascular
cause of death
What
cholesterol
5
×
drug
lowering
5
×
medicines
medco
fda
new
twice
aces
alnylam
announced
approved
based
big
bringing
ceo
clears
closer
combo
data
drugs
esperion
esperion’s
evidence
expensive
faces
filing
financial
flexible
foe
healthcare
heart
hint
inched
inclisiran
inhibitors
key
known
lasting
levels
Language
unset
Current search:
cholesterol
×
lowering
×
" life sciences "
×
@xconomy.com
4 years ago
Esperion’s Combo Pill for Lowering Cholesterol Levels Wins FDA Nod
@xconomy.com
4 years ago
MedCo Preps for FDA Filing as Cholesterol Drug Clears Last Two Tests
@xconomy.com
4 years ago
As Cholesterol Drug Aces Big Test, MedCo CEO Open to Flexible Pricing
@xconomy.com
4 years ago
New PCSK9 Cholesterol Drug Faces Tough Foe. (Hint: Not Cholesterol.)
@xconomy.com
4 years ago
MedCo Touts New Data for Long-Lasting Heart Drug as Reckoning Looms